D-(+)-Glucurono-3,6-lactone - CAS 32449-92-6
Catalog: |
BB021291 |
Product Name: |
D-(+)-Glucurono-3,6-lactone |
CAS: |
32449-92-6 |
Synonyms: |
(2R)-2-[(2S,3R,4S)-3,4-dihydroxy-5-oxo-2-oxolanyl]-2-hydroxyacetaldehyde; D-Glucuronic acid, γ-lactone; D-Glucofuranurono-6,3-lactone; D-Glucuronic acid lactone; D-Glucurono-6,3-lactone; D-Glucurono-γ-lactone; D-Glucuronolactone; Dicurone; Glucoxy; Glucurolactone; Glucurone; Glucuronolactone; Guronsan; NSC 656 |
IUPAC Name: | (2R)-2-[(2S,3R,4S)-3,4-dihydroxy-5-oxooxolan-2-yl]-2-hydroxyacetaldehyde |
Description: | D-(+)-Glucurono-3,6-lactone is used for treating canine hepatitis. |
Molecular Weight: | 176.12 |
Molecular Formula: | C6H8O6 |
Canonical SMILES: | C(=O)C(C1C(C(C(=O)O1)O)O)O |
InChI: | InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h1-5,8-10H/t2-,3+,4-,5+/m0/s1 |
InChI Key: | UYUXSRADSPPKRZ-SKNVOMKLSA-N |
Boiling Point: | 403.5±28.0°C at 760 mmHg |
Melting Point: | 177.5°C |
Density: | 1.749 g/cm3 |
LogP: | -2.80660 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P301+P312, P330, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113512527-A | Mesenchymal stem cell culture medium and application thereof | 20210809 |
CN-113479880-A | Preparation process of modified activated carbon | 20210804 |
CN-113367248-A | Feed, preparation method thereof and feeding method of laying hens | 20210617 |
CN-113367249-A | Additive and application thereof | 20210617 |
CN-113265436-A | Method for efficient biotransformation of anthraquinone products from traditional Chinese medicine sources by using streptomyces coeruleorubidus DM | 20210607 |
PMID | Publication Date | Title | Journal |
31811891 | 20200130 | d-Glucuronolactone attenuates para-xylene-induced defects in neuronal development and plasticity in Xenopus tectum in vivo | Toxicology |
22820017 | 20121101 | In vivo role of aldehyde reductase | Biochimica et biophysica acta |
22928735 | 20120921 | Glycosidase inhibition by all 10 stereoisomeric 2,5-dideoxy-2,5-iminohexitols prepared from the enantiomers of glucuronolactone | The Journal of organic chemistry |
22736508 | 20120723 | Scalable syntheses of both enantiomers of DNJNAc and DGJNAc from glucuronolactone: the effect of N-alkylation on hexosaminidase inhibition | Chemistry (Weinheim an der Bergstrasse, Germany) |
22730801 | 20120501 | [Energy drinks: an unknown risk] | La Revue du praticien |
Complexity: | 202 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 4 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 176.03208797 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 6 |
Hydrogen Bond Donor Count: | 3 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 176.03208797 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 104 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -1.8 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS